Cases & Deals

  • Home
  • Practices
  • Canaccord Genuity underwrites follow-on public offering of Common Stock by GenMark Diagnostics

Share

Canaccord Genuity underwrites follow-on public offering of Common Stock by GenMark Diagnostics

June 2011

Client(s) Canaccord Genuity Inc.

Jones Day advised Canaccord Genuity Inc., as representative of the underwriters, in connection with the $34.5 million follow-on public offering of Common Stock on the NASDAQ Global Market by GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.